阿司匹林对中国早产型子痫前期高危女性母体血流动力学的影响:纵向研究
这项前瞻性纵向病例对照研究纳入857例中国单胎妊娠女性,比较早产型子痫前期低危与高危女性(高危者部分接受阿司匹林)的母体血流动力学。高危组(无论是否用阿司匹林)整个孕期MAP和SVR较高、CO和SV较低(均P<0.001),两个高危组间无显著差异;阿司匹林预防对改善血流动力学作用有限。
要点
- 高危组较l低危组整个孕期MAP和SVR更高、CO和SV更低(均P<0.001)。
- 接受与未接受阿司匹林的两个高危组间血流动力学参数无显著差异。
- 阿司匹林预防对改善高危女性母体血流动力学作用有限。
核心结论
- 中国早产型子痫前期高危与低危女性孕期母体血流动力学适应存在显著差异。
- 高危女性自早孕期即表现MAP和SVR升高、SV和CO降低,并持续整个孕期。
- 阿司匹林预防对改善高危女性母体血流动力学作用有限,凸显需要替代策略应对血流动力学适应不良。
研究设计与样本
- 前瞻性纵向病例对照研究,纳入857例单胎妊娠中国女性,2020年2月至2023年3月于中国香港特别行政区威尔士亲王医院参与早产型子痫前期早孕期筛查与预防项目。
- 早产型子痫前期(37周前分娩)风险采用胎儿医学基金会联合试验(母体因素联合MAP、子宫动脉搏动指数和胎盘生长因子)判定。
- 研究人群分三组:高危(校正风险≥1:100)接受阿司匹林者、高危未接受阿司匹林者、低危(校正风险<1:100)按母亲年龄、体重和扫描日期1:1匹配者。
- 高危接受阿司匹林者按母体体重给药(<40 kg用100 mg,≥40 kg用160 mg),自孕16周前开始至孕36周、分娩或36周前诊断子痫前期时停药。
- 于孕12+0至15+6周、20+0至24+6周和30+0至37+6周用二维经胸超声心动图评估HR、SV、CO和SVR,MAP用孕期验证设备测量,数据经Log10转换后行校正多水平线性混合效应分析。
主要发现
- 研究纳入低危组389例、高危接受阿司匹林组379例、高危未接受阿司匹林组89例。
- 三组间整个孕期log10 HR的估计边际均值无显著差异。
- 与低危组相比,两个高危组(接受和未接受阿司匹林)整个孕期log10 MAP和log10 SVR的估计边际均值持续更高,log10 CO和log10 SV的估计边际均值持续更低(均P<0.001)。
- 接受与未接受阿司匹林的两个高危组间log10 SV、CO、MAP和SVR的估计边际均值轨迹不同,但这些参数无显著差异。
临床怎么用
- 作者认为,阿司匹林预防对改善早产型子痫前期高危女性的母体血流动力学作用有限,凸显需要替代策略应对高危女性的血流动力学适应不良。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To compare the maternal hemodynamics of Chinese women at low and at high risk for preterm pre-eclampsia (PE) and assess the differences in hemodynamic parameters between high-risk women with or without prophylactic aspirin. METHODS: This was a prospective longitudinal case-control study of 857 Chinese women with a singleton pregnancy who participated in the first-trimester screen-and-prevent program for PE at the Prince of Wales Hospital, Hong Kong SAR, China, between February 2020 and March 2023. The risk of developing preterm PE (delivery before 37 weeks) was determined using the Fetal Medicine Foundation combined test (maternal factors combined with mean arterial pressure (MAP), uterine artery pulsatility index and placental growth factor). The study population comprised three groups of women: (1) women at high risk (adjusted risk ≥ 1:100) for preterm PE who received 100 mg or 160 mg of aspirin according to maternal weight (< 40 kg or ≥ 40 kg, respectively), starting before 16 weeks' gestation until 36 weeks' gestation, until delivery or until PE was diagnosed if before 36 weeks; (2) women at high risk for preterm PE who did not receive aspirin; and (3) women at low risk (adjusted risk < 1:100) for preterm PE who were matched 1:1 to high-risk women, according to maternal age, weight and date of the scan. MAP was measured using a device validated for use in pregnancy, and heart rate (HR), stroke volume (SV), cardiac output (CO) and systemic vascular resistance (SVR) were evaluated using two-dimensional transthoracic echocardiography at 12 + 0 to 15 + 6 weeks, 20 + 0 to 24 + 6 weeks and 30 + 0 to 37 + 6 weeks' gestation. Log10 transformation was applied to fit the data to a Gaussian distribution. An adjusted multilevel linear mixed-effects analysis was performed to compare the longitudinal changes of maternal hemodynamics across gestation between the three study groups. RESULTS: This study comprised 389 women at low risk of preterm PE, 379 women at high risk of preterm PE who received aspirin and 89 women at high risk who did not receive aspirin. There was no significant difference in the estimated marginal mean (EMmean) of log10 HR across gestation among the three study groups. Compared with the low-risk group, both high-risk groups (with and without aspirin) exhibited consistently higher EMmean of log10 MAP and log10 SVR, and lower EMmean of log10 CO and log10 SV throughout gestation (all P < 0.001). Although maternal hemodynamic trajectories differed across the EMmean of log10 SV, CO, MAP and SVR between high-risk women with aspirin and those without, there were no significant differences in these parameters between the two high-risk groups. CONCLUSION: This study highlights the significant differences in maternal hemodynamic adaptation during pregnancy between Chinese women at high risk and those at low risk for preterm PE. Compared with low-risk women, high-risk women exhibited increased MAP and SVR, along with reduced SV and CO as early as the first trimester, and these alterations persisted throughout gestation. Notably, aspirin prophylaxis showed a limited effect on improving maternal hemodynamics in women at high risk for preterm PE, highlighting the need for alternative strategies to address the hemodynamic maladaptation in high-risk women. © 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Wang X, Lin J, Chen Y, et al. Effect of aspirin on maternal hemodynamics in Chinese women at high risk for preterm pre-eclampsia: longitudinal study. Ultrasound Obstet Gynecol. 2025. PMID: 40939581. doi:10.1002/uog.70027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。